At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 169 enrolled
Drug / intervention
Heatwrap 1device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Open Label Study To Evaluate The Safety, Tolerability And On-Body Temperature Of A Disposable Heatwrap Device For The Lower Back
In Brief
A Phase 3 clinical trial evaluating Heatwrap 1 for Healthy. Completed, enrolled 169 participants.
Detailed Summary
The objectives of this study are to evaluate the dermal safety and on-body temperature of a disposable heatwrap product when worn while in a supine position for five consecutive days. The product will be worn on the back for approximately 8 hours per 24 hour period.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
Countries--
Collaborators--
Timeline
Phase 3CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2010
First PostedJan 2010
Primary CompletionFeb 2010
TodayJul 2026
First PostedJan 25, 2010
Enrollment StartJan 1, 2010
Primary CompletionFeb 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 16.4 years ago
Interventions
Heatwrap 1device
8 hours continuous topically-applied heat